{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:36:24Z","timestamp":1775705784443,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The use of statin therapy on the prevention of atherosclerotic cardiovascular disease (ASCVD) is recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA); nevertheless, its validation on primary aldosteronism (PA) patients has not been reported. We investigated the risk of incident ASCVD in middle-aged patients with PA compared with essential hypertension (EH) based on ACC\/AHA recommendations. We enrolled 461 PA patients and 553 EH patients. Even though the ratio of metabolic syndrome in each group was similar, the PA group had higher systolic blood pressures, higher low-density lipoprotein levels, higher plasma aldosterone concentration (PAC), lower high-density lipoprotein levels, and higher 10-year ASCVD compared to the EH group. The discriminative power for predicting ASCVD by the recommended statin use from the ACC\/AHA guidelines was proper in the PA group (i.e., under the receiver operating characteristic curve (95% confidence interval; 0.94 (0.91\u20130.96)). The generalized additive model showed patients with PAC higher than 60 ng\/dL accompanying the standard timing of the statin use suggested by the ACC\/AHA. The ACC\/AHA guidelines have good discriminative power in the prediction of middle-aged high-risk hypertensive patients, while PAC identifies those high-risk individuals who may benefit from early statin therapy.<\/jats:p>","DOI":"10.3390\/jcm7110382","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T10:40:48Z","timestamp":1540377648000},"page":"382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease"],"prefix":"10.3390","volume":"7","author":[{"given":"Jui-Hsiang","family":"Lin","sequence":"first","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Division of Nephrology and Sinwu Branch, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan 330, Taiwan"},{"name":"Faculty of Medicine, National Yang-Ming University, Taipei 112, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-7755","authenticated-orcid":false,"given":"Yu-Feng","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei 100, Taiwan"},{"name":"Department of Internal Medicine, Division of Nephrology, National Taiwan University Hospital, Taipei 100, Taiwan"},{"name":"Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Sinwu Branch, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan 330, Taiwan"},{"name":"Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan 320, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-5054","authenticated-orcid":false,"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Ministry of Health and Welfare, Shuang Ho Hospital, Taipei Medical University, Taipei 235, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Chueh","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine and Glickman Urological and Kidney Institute, Cleveland Clinic, OH 441, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":false,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Shinn","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"ref_1","first-page":"598","article-title":"Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide","volume":"100","author":"Wu","year":"2001","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: The Framingham Heart Study","volume":"117","author":"Vasan","year":"2008","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: Primary aldosteronism\u2014Changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of Aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jacc.2014.05.056","article-title":"Accuracy of Statin Assignment Using the 2013 AHA\/ACC Cholesterol Guideline Versus the 2001 NCEP ATP III Guideline: Correlation With Atherosclerotic Plaque Imaging","volume":"64","author":"Johnson","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 American College of Cardiology\/American Heart Association guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2009.89","article-title":"Primary Aldosteronism: Diagnostic Accuracy of the Losartan and Captopril Tests","volume":"22","author":"Wu","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1470320310391329","article-title":"Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)","volume":"12","author":"Kuo","year":"2011","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1210\/jc.2018-00746","article-title":"miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas","volume":"103","author":"Peng","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wu, C.H., Yang, Y.W., Hu, Y.H., Tsai, Y.C., Kuo, K.L., Lin, Y.H., Hung, S.C., Wu, V.C., and Wu, K.D. (2013). Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067417"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism\u2014The consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma","volume":"54","author":"Wu","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1038\/srep11396","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/HJH.0b013e3283550f93","article-title":"Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism","volume":"30","author":"Lin","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-7120-3-17","article-title":"Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?","volume":"3","author":"Foppa","year":"2005","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_22","unstructured":"Health Promotion Administration, and Ministry of Health and Welfare (2018, April 08). Metabolic Syndrome, Available online: http:\/\/www.hpa.gov.tw\/BHPNet\/Web\/HealthTopic\/Topic.aspx?id=201109140001."},{"key":"ref_23","first-page":"626335","article-title":"Urinary \u03c0-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery","volume":"2016","author":"Shu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jc.2009-2204","article-title":"Adipokines and cardiometabolic profile in primary hyperaldosteronism","volume":"95","author":"Iacobellis","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lin, Y.F., Chen, L., Lin, S.L., Yeh, Y.C., Huang, T.M., Chou, Y.H., Chang, F.C., Chen, Y.T., Yang, S.Y., and Lai, T.S. (2018). Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease. J. Hypertens.","DOI":"10.1097\/HJH.0000000000001876"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"906327","DOI":"10.1155\/2012\/906327","article-title":"Association of aldosterone and cortisol with cardiovascular risk factors in prehypertension stage","volume":"2012","author":"Syed","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.115.016759","article-title":"Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects","volume":"132","author":"Baudrand","year":"2015","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/dc17-2409","article-title":"National Taiwan University Hospital Study Group on Acute Renal Failure (NSARF). New-Onset Diabetes after Acute Kidney Injury Requiring Dialysis","volume":"41","author":"Lin","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Primary aldosteronism and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/11\/382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:25:57Z","timestamp":1760196357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/11\/382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["jcm7110382"],"URL":"https:\/\/doi.org\/10.3390\/jcm7110382","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]}}}